menu search

Sanofi in $1 billion deal to buy u.s.-based amunix pharma

Drugmaker Sanofi SA will buy Amunix pharmaceuticals Inc for an upfront payment of about $1 billion, mar...

December 21, 2021, 1:12 am

Sanofi in $1 billion deal to buy u.s.-based amunix pharma

Drugmaker Sanofi SA will buy Amunix pharmaceuticals Inc for an upfront payment of about $1 billion, mar...

December 21, 2021, 1:12 am

Pharma could be fabulous in 2022

pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...

December 20, 2021, 1:35 pm

Pharma could be fabulous in 2022

pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...

December 20, 2021, 1:35 pm

Pharma could be fabulous in 2022

pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...

December 20, 2021, 1:35 pm

Xeris biopharma: market is snubbing the strongbridge acquisition

Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...

December 19, 2021, 7:52 pm

Xeris biopharma: market is snubbing the strongbridge acquisition

Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...

December 19, 2021, 7:52 pm

Xeris biopharma: market is snubbing the strongbridge acquisition

Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...

December 19, 2021, 7:52 pm

Takeda pharmaceutical: underappreciated potential

ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...

December 19, 2021, 10:46 am

Takeda pharmaceutical: underappreciated potential

ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...

December 19, 2021, 10:46 am

Takeda pharmaceutical: underappreciated potential

ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...

December 19, 2021, 10:46 am

Moderna drops covid-19 vaccine patent application, cooling legal fight with government

The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...

December 17, 2021, 7:53 pm

Moderna drops covid-19 vaccine patent application, cooling legal fight with government

The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...

December 17, 2021, 7:53 pm

Moderna drops covid-19 vaccine patent application, cooling legal fight with government

The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...

December 17, 2021, 7:53 pm

Big pharma innovation outlook looks healthy

pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...

December 17, 2021, 1:20 pm

Big pharma innovation outlook looks healthy

pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...

December 17, 2021, 1:20 pm

Big pharma innovation outlook looks healthy

pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...

December 17, 2021, 1:20 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...

December 17, 2021, 1:16 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...

December 17, 2021, 1:16 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...

December 17, 2021, 1:16 pm


Search within

Pages Search Results: